Physician profile
Michael Norris
NPI 1114023850
$2,700.92
in general payments reported to CMS, 2019-2025
38 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $221 · 2021: $447 · 2022: $645 · 2023: $535 · 2024: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,006.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $244.78 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $202.22 | 2023-2024 | Orgovyx |
| Astellas Pharma US INC | $196.10 | 2020-2022 | |
| Myovant Sciences INC. | $174.40 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $174.27 | 2022 | |
| Tolmar, INC. | $161.47 | 2023 | |
| Endo Pharmaceuticals INC. | $157.07 | 2019-2023 | Aveed, Xiaflex |
| Comsort, INC | $100.00 | 2019 | |
| Boston Scientific Corporation | $94.31 | 2019-2024 | Rezum Generator |
| Janssen Biotech, INC. | $84.32 | 2021-2024 | Erleada |
| Teleflex LLC | $73.70 | 2021-2024 | Urolift |
| Pfizer INC. | $72.10 | 2019-2022 | |
| Procept Biorobotics Corporation | $70.02 | 2023 | Aquabeam Robotic System |
| Urogen Pharma, INC. | $69.24 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $68.36 | 2024 | Prolaris |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $66.12 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $61.55 | 2019-2021 | |
| Acerus Pharmaceuticals Corporation | $60.19 | 2020-2022 | |
| Blue Earth Diagnostics | $59.06 | 2020-2021 | |
| Coloplast Corp | $54.12 | 2019-2022 | |
| Endo USA, INC. | $48.75 | 2024 | Xiaflex, Aveed |
| Accord Healthcare, INC. | $45.84 | 2022-2024 | |
| Antares Pharma, INC. | $40.71 | 2019-2021 | |
| Neotract INC. | $39.10 | 2019 | |
| Progenics Pharmaceuticals, INC. | $32.15 | 2021-2022 | |
| Olympus America INC. | $31.51 | 2019-2022 | |
| Cook Medical LLC | $28.47 | 2019 | |
| Curium US LLC | $22.02 | 2023 | |
| Merck Sharp & Dohme LLC | $21.11 | 2022 | |
| Novo Nordisk INC | $21.08 | 2024 | |
| Alnylam Pharmaceuticals INC. | $20.61 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $20.00 | 2020 | |
| Immunitybio, INC. | $19.49 | 2024 | |
| Becton, Dickinson and Company | $16.75 | 2024 | Bard Urinary Drainage Bag |
| Ferring Pharmaceuticals INC. | $13.76 | 2019 | |
| Mission Pharmacal Company | $12.49 | 2019 | |
| Srs Medical Systems, INC. | $11.91 | 2022 | |
| Allergan, INC. | $11.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Norris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.